To further determine the regulatory role of CBS and ATF3 in cancer cells response to ferroptosis, we analyzed data from the NCI Transcriptional Pharmacodynamics Workbench [31], which contains expression data for 12,704 genes in the NCI-60 panel of cell lines exposed to sorafenib, a candidate ferroptosis inducer [32]. This evidence concerns the gene ATF3 and cancer.